Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Pozycja w akcjach #27217
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Cena akcji
$0.28100602
Kapitalizacja rynkowa
$31.66M
Zmiana (1 dzień)
-0.62%
Zmiana (1 rok)
-12.35%
Kraj
AU
Handel Medical Developments International Limited (MVP)

Kategoria

Healthcare
Historia ceny akcji dla Medical Developments International Limited (MVP)
Najwyższa cena zamknięcia: $0.30 dnia 2026-10-01

Najniższa cena zamknięcia: $6.80 dnia 2020-01-01
Historia cen akcji firmy Medical Developments International Limited od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 12.26%
2025 -2.01%
2024 -32.24%
2023 -73.18%
2022 -53.64%
2021 -11.84%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$161.15 20.52%
DE
$40.31 42.59%
JP
$212.49 24.09%
CH
$19.19 -0.09%
IN